The Erwinia amylovora PhoPQ system is involved in resistance to antimicrobial peptide and suppresses gene expression of two novel type III secretion systems

Microbiological Research
Sridevi NakkaYoufu Zhao

Abstract

The PhoPQ system is a pleiotropic two-component signal transduction system that controls many pathogenic properties in several mammalian and plant pathogens. Three different cues have been demonstrated to activate the PhoPQ system including a mild acidic pH, antimicrobial peptides, and low Mg(2+). In this study, our results showed that phoPQ mutants were more resistant to strong acidic conditions (pH 4.5 or 5) than that of the wild-type (WT) strain, suggesting that this system in Erwinia amylovora may negatively regulate acid resistance gene expression. Furthermore, the PhoPQ system negatively regulated gene expression of two novel type III secretion systems in E. amylovora. These results are in contrast to those reported for the PhoPQ system in Salmonella and Xanthomonas, where it positively regulates type III secretion system and acid resistance. In addition, survival of phoPQ mutants was about 10-fold lower than that of WT when treated with cecropin A at pH 5.5, suggesting that the PhoPQ system renders the pathogen more resistant to cecropin A.

References

Sep 1, 1997·Nucleic Acids Research·S F AltschulD J Lipman
Apr 4, 2000·Current Opinion in Microbiology·J A Hoch
Feb 27, 2001·Journal of Bacteriology·E A Groisman
Feb 10, 2004·Applied and Environmental Microbiology·Antje BurseMatthias S Ullrich
Jun 19, 2004·Journal of Bacteriology·Kimberly A Walker, Virginia L Miller
Aug 13, 2005·Cell·Martin W BaderSamuel I Miller
Oct 29, 2005·FEMS Microbiology Letters·Chang-Sik Oh, Steven V Beer
Aug 9, 2006·Nature Reviews. Microbiology·Eduardo A Groisman, Chakib Mouslim
Aug 12, 2006·Cell·Colin Dale, Nancy A Moran
Jan 19, 2007·Molecular Microbiology·J Christian Perez, Eduardo A Groisman
May 1, 2007·Molecular Cell·Lynne R ProstSamuel I Miller
Feb 25, 2009·Molecular Plant Pathology·Dongping WangYoufu Zhao
Mar 3, 2009·Proceedings of the National Academy of Sciences of the United States of America·J Christian Perez, Eduardo A Groisman

❮ Previous
Next ❯

Citations

Apr 3, 2012·Journal of Bacteriology·Julieta BarchiesiEleonora García Véscovi
Oct 7, 2015·Frontiers in Plant Science·Urooj Fatima, Muthappa Senthil-Kumar
Apr 13, 2017·Environmental Microbiology·Yueming HuYejun Wang
Aug 14, 2019·Environmental Microbiology·Yingpeng XieXin Deng

❮ Previous
Next ❯

Related Concepts

Related Feeds

CRISPR & Staphylococcus

CRISPR-Cas system enables the editing of genes to create or correct mutations. Staphylococci are associated with life-threatening infections in hospitals, as well as the community. Here is the latest research on how CRISPR-Cas system can be used for treatment of Staphylococcal infections.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.